In addition, Centocor () has developed an anti-human IL-13 antibody that is effective in animal models of asthma [201,205] and IMA-638 (IgG1, kappa), a humanized antibody to human IL-13 from Wyeth Research is effective in animal models of asthma [202,206]. Here, IL13 is linked to asthma.